236 related articles for article (PubMed ID: 33643921)
1. Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
Adashek JJ; Zhang Y; Skelton WP; Bilotta A; Chahoud J; Zemp L; Li J; Dhillon J; Manley B; Spiess PE
Front Oncol; 2020; 10():627025. PubMed ID: 33643921
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience.
Silagy AW; Mano R; Blum KA; DiNatale RG; Marcon J; Tickoo SK; Reznik E; Coleman JA; Russo P; Hakimi AA
Urology; 2020 Feb; 136():169-175. PubMed ID: 31726184
[TBL] [Abstract][Full Text] [Related]
3. Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.
Blum KA; Silagy AW; Knezevic A; Weng S; Wang A; Mano R; Marcon J; DiNatale RG; Sanchez A; Tickoo S; Gupta S; Motzer R; Haas NB; Kim SE; Uzzo RG; Coleman JA; Hakimi AA; Russo P
BJU Int; 2024 Feb; 133(2):169-178. PubMed ID: 37589200
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cytoreductive Nephrectomy and Targeted Therapy on Outcomes of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Population-Based Analysis.
Al-Juhaishi T; Deng X; Bandyopadhyay D; Paul A
Cureus; 2022 May; 14(5):e25395. PubMed ID: 35774668
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.
Hahn AW; Kotecha RR; Viscuse PV; Pieretti AC; Wiele AJ; Jonasch E; Lee CH; Gao J; Zurita AJ; Shah AY; Campbell MT; Sharma P; Motzer RJ; Russo P; Wood CG; Tannir NM; Voss MH; Karam JA; Hakimi AA; Msaouel P
Eur Urol Focus; 2023 Sep; 9(5):734-741. PubMed ID: 36863962
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of sarcomatoid features in metastatic renal cell carcinoma treated with cytoreductive nephrectomy and targeted therapy.
Cortese BD; Chelluri R; Xia L; Ostrowski DA; Roberson DS; Strother M; Ding JM; Schwartz L; Lee DJ; Guzzo TJ
Am J Clin Exp Urol; 2022; 10(5):327-333. PubMed ID: 36313210
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
8. The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature.
Studentova H; Rusarova N; Ondruskova A; Zemankova A; Student V; Skanderova D; Melichar B
Curr Oncol; 2022 Aug; 29(8):5475-5488. PubMed ID: 36005171
[TBL] [Abstract][Full Text] [Related]
9. A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database.
Ji B; Li D; Fu S; Zhang Z; Yang T; Wu Y; Zuo Y; Xu Z; Yu N
Med Sci Monit; 2020 Jun; 26():e921297. PubMed ID: 32516796
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Kyriakopoulos CE; Chittoria N; Choueiri TK; Kroeger N; Lee JL; Srinivas S; Knox JJ; Bjarnason GA; Ernst SD; Wood LA; Vaishampayan UN; Agarwal N; Pal SK; Kanesvaran R; Rha SY; Yuasa T; Donskov F; North SA; Heng DY; Rini BI
Clin Genitourin Cancer; 2015 Apr; 13(2):e79-85. PubMed ID: 25450036
[TBL] [Abstract][Full Text] [Related]
11. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
Adibi M; Thomas AZ; Borregales LD; Merrill MM; Slack RS; Chen HC; Sircar K; Murugan P; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
Urol Oncol; 2015 Oct; 33(10):427.e17-23. PubMed ID: 26004164
[TBL] [Abstract][Full Text] [Related]
12. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
13. Robotic-assisted cytoreductive partial nephrectomy for metastatic sarcomatoid renal cell carcinoma following dramatic response to combination immunotherapy in a young female.
Bhanji Y; Baraban E; Antonucci B; Ged Y; Singla N
Kidney Cancer J; 2023 Jun; 21(2):15-18. PubMed ID: 37981948
[TBL] [Abstract][Full Text] [Related]
14. Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data.
Janisch F; Kienapfel C; Fühner C; Klotzbücher T; Marks P; Hillemacher T; Meyer CP; Iwata T; Parizi MK; Sauter G; Fisch M; Shariat SF; Dahlem R; Rink M
Front Surg; 2021; 8():763271. PubMed ID: 34869564
[No Abstract] [Full Text] [Related]
15. Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology.
Salgia NJ; Aubrecht WM; Wang L; Ram B; Wasik BJ; Khan A; Attwood K; Daza J; Long MD; Eng KH; Xu B; Muhitch JB; Kauffman EC
Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38480032
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?
Shuch B; Said J; La Rochelle JC; Zhou Y; Li G; Klatte T; Kabbinaavar FF; Pantuck AJ; Belldegrun AS
J Urol; 2009 Nov; 182(5):2164-71. PubMed ID: 19758641
[TBL] [Abstract][Full Text] [Related]
17. The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis.
Tully KH; Berg S; Paciotti M; Janisch F; Reese SW; Noldus J; Shariat SF; Choueiri T; Müller G; McGregor B; Chang SL; Trinh QD; Mossanen M
Clin Genitourin Cancer; 2023 Feb; 21(1):63-68. PubMed ID: 36517393
[TBL] [Abstract][Full Text] [Related]
18. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
Merrill MM; Wood CG; Tannir NM; Slack RS; Babaian KN; Jonasch E; Pagliaro LC; Compton Z; Tamboli P; Sircar K; Pisters LL; Matin SF; Karam JA
Urol Oncol; 2015 Apr; 33(4):166.e21-9. PubMed ID: 25700975
[TBL] [Abstract][Full Text] [Related]
19. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients.
Alevizakos M; Gaitanidis A; Nasioudis D; Msaouel P; Appleman LJ
Clin Genitourin Cancer; 2019 Jun; 17(3):e447-e453. PubMed ID: 30799129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
